The Parkinson'<sup>s</sup> Vitals Dashboard

*J. Pers. Med.* **2022**, *12*, x FOR PEER REVIEW 4 of 7

comorbidities.

**Figure 2.** A proposed "Parkinson's vitals dashboard" comprising the vitals and some specific measures that should be undertaken. Divided into the *essentials* which should be performed annually at review and *consider* some optional investigations and assessments if time permits. ABPM ambulatory blood pressure monitoring; AXR abdominal x-ray; CLO campylobacter-like organism test; CPS co-morbidities polypharmacy score; CRP C-reactive protein; DEXA dual energy x-ray absorptiometry scan; ESS Epworth Sleepiness Scale; HADS Hospital anxiety and depression scale; HY Hoehn and Yahr, H Pylori helicobacter pylori; ICD impulse control disorder; KPP King's Parkinson's Pain; MCI mild cognitive impairment; MDS-UPDRS Movement disorder society unified Parkinson's disease rating scale; MoCA Montreal Cognitive Assessment; NMS nonmotor symptoms; NMS Quest NMS questionnaire; OSDI Ocular Surface Disease Index; PDSS PD Sleep Scale; PKG **Figure 2.** A proposed "Parkinson's vitals dashboard" comprising the vitals and some specific measures that should be undertaken. Divided into the *essentials* which should be performed annually at review and *consider* some optional investigations and assessments if time permits. ABPM ambulatory blood pressure monitoring; AXR abdominal X-ray; CLO campylobacter-like organism test; CPS co-morbidities polypharmacy score; CRP C-reactive protein; DEXA dual energy X-ray absorptiometry scan; ESS Epworth Sleepiness Scale; HADS Hospital anxiety and depression scale; HY Hoehn and Yahr, H Pylori helicobacter pylori; ICD impulse control disorder; KPP King's Parkinson's Pain; MCI mild cognitive impairment; MDS-UPDRS Movement disorder society unified Parkinson's disease rating scale; MoCA Montreal Cognitive Assessment; NMS nonmotor symptoms; NMS Quest NMS questionnaire; OSDI Ocular Surface Disease Index; PDSS PD Sleep Scale; PKG Parkinson's kinetograph; SCOPA-motor Scales for outcomes in Parkinson's disease motor function; UDRS unified dystonia rating scale; UDysRS unified dyskinesia rating scale.

#### **2. Conclusions**

A dashboard of the vital symptoms, which are enablers of wellness in PD, needs to be considered in every patient with PD, regardless of stage and setting, see Figure 2. The process is simple and needs to be preferably recorded on an annual basis, as part of their regular review. Attention to these vitals would ensure continuing good care for PwP and function as the cornerstone of a holistic personalised modern symptom-driven management strategy.

**Author Contributions:** Conceptualization, K.R.C., N.T., M.A.Q.; methodology, K.R.C., N.T., M.A.Q.; validation, K.R.C., N.T., M.A.Q., I.M., C.F.-P.; formal analysis, N.T., M.A.Q.; investigation, K.R.C., N.T., M.A.Q., I.M., C.F.-P.; data curation K.R.C., N.T., M.A.Q., I.M., C.F.-P.; writing—original draft preparation, K.R.C., N.T., M.A.Q.; writing—review and editing, K.R.C., N.T., M.A.Q., I.M., C.F.-P.; visualization, K.R.C., N.T., M.A.Q., I.M., C.F.-P.; supervision, K.R.C., N.T., M.A.Q., I.M., C.F.-P.; project administration, K.R.C., N.T., M.A.Q. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research received no external funding.

**Conflicts of Interest:** The authors declare no conflict of interest.

#### **References**


#### *Article*
